Skip to main content
. 2021 May 12;12(11):1743–1751. doi: 10.1111/1759-7714.13989

TABLE 2.

The univariate and multivariate analyses of factors associated with overall survival in LUAD cases

Variable N (%) Univariate analysis Multivariate analysis
HR (95% CI) p value HR (95% CI) p value
Age (years) <60 122 (50.8) 0.548 (0.399–0.753) <0.001 0.535 (0.387–0.739) <0.001
≥60 118 (49.2)
Gender Male 143 (59.6) 1.223 (0.887–1.685) 0.220 1.279 (0.915–1.789) 0.150
Female 97 (40.4)
Smoking history Smokers 108 (45.0) 0.784 (0.574–1.072) 0.127
Nonsmokers 132 (55.0)
Differentiation Poor 133 (55.4) 1.248 (1.063–1.465) 0.007 1.094 (0.921–1.299) 0.306
Moderate and high 107 (44.6)
T 1–2 176 (73.3) 0.737 (0.623–0.872) <0.001 0.625 (0.440–0.887) 0.009
3–4 64 (36.7)
N 0–1 148 (61.7) 0.483 (0.353–0.661) <0.001 0.492 (0.354–0.684) <0.001
2 92 (38.3)
TNM stage 1–2 129 (53.8) 0.494 (0.361–0.677) <0.001
3–4 111 (46.2)
PD‐L1 Positive 45 (18.8) 1.517 (1.041–2.210) 0.030
Negative 195 (81.3)
CD47 Positive 172 (71.7) 1.470 (1.026–2.106) 0.036
Negative 68 (28.3)
PD‐L1/CD47 Co‐expression 35 (14.6) 1.815 (1.204–2.736) 0.004 1.549 (1.015–2.364) 0.043
Others 205 (85.4)

Abbreviations: CD47, cluster of differentiation 47; CI, confidence interval; HR hazard ratio; LUAD, lung adenocarcinoma; PD‐L1, programmed cell death‐ligand 1.